Evidence map›Paper›PMID 35252040›Full record

ArticleFrontiers in cellular and infection microbiology2022

Probiotic

Rongling Zhang, Zhengguang Li, Xinyi Gu, Jiancun Zhao, Tingting Guo, Jian Kong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. Effects ofAnimals : an open access journal from MDPI · 2026
    Article
  2. Review
  3. Protective Effect of Synbiotic Supplementation AgainstAnimals : an open access journal from MDPI · 2026
    Article
  4. Article
  5. DietaryAntibiotics (Basel, Switzerland) · 2026
    Article
  6. Antibiotic Alternatives and Next-Generation Therapeutics forAntibiotics (Basel, Switzerland) · 2025
    Review
  7. Microorganisms · 2025
    Article
  8. Colonic Submucosa Targeted Delivery of Probiotic and Rhein for Ulcerative Colitis Treatment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Microorganisms · 2025
    Article
  13. eLife · 2024
    Article
  14. Evaluating the Safety ofMicroorganisms · 2024
    Article
  15. Article
  16. Effects of a novelHeliyon · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Protective Effects ofVeterinary sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rongling ZhangState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Zhengguang LiState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Xinyi GuState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Jiancun ZhaoState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Tingting GuoState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Jian KongState Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
Shandong University · CNState Key Laboratory of Microbial Technology

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enteric diseases caused by

Indexed as

ProbioticsSalmonella InfectionsAnimalsBacillus subtilisChickensIntestinal MucosaBacillus subtilisexclusion activityinflammatory cytokinesintestinal barrierSalmonella infectiontight junction

Identifiers

PMID35252040
PMCPMC8889029
OpenAlexW4213129014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.